Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
As of today, Merck(MRK) shares are valued at $112.77. The company's market cap stands at 278.32B, with a P/E ratio of 16.08 and a dividend yield of 2.8%.
As of 2026-04-22, Merck(MRK) stock has fluctuated between $111.91 and $117.98. The current price stands at $112.77, placing the stock +0.8% above today's low and -4.4% off the high.
The Merck(MRK)'s current trading volume is 12.77M, compared to an average daily volume of 10.19M.
During the past year, Merck(MRK) stock moved between $73.31 at its lowest and $125.14 at its peak.
During the past year, Merck(MRK) stock moved between $73.31 at its lowest and $125.14 at its peak.
MRK News
Merck (NYSE:MRK) received U.S. FDA approval for IDVYNSO, a new two drug, non INSTI, tenofovir free HIV regimen. The company reported that a late stage trial of...
Merck (MRK) announced that the U.S. Food and Drug Administration approved Idvynso, a new, two-drug single-tablet regimen of 100 mg doravirine and 0.25 mg islatr...
Clear cell RCC is the most common form of kidney cancer, accounting for roughly 75–80% of cases. Triplet Regimen Misses Primary Endpoints The trial evaluated th...
Analyst ratings
67%
of 30 ratingsMore MRK News
BofA notes Merck (MRK) and Eisai (ESAIY) announced that the Phase 3 LITESPARK-012 trial evaluating combination regimens for the first-line treatment of patients...
Merck (MRK) and Eisai (ESALF) announced on Tuesday that a late-stage trial evaluating two combination regimens involving the U.S. pharma giant's anti-PD1 inhibi...
Advertisement Merck stock performance snapshot Merck (MRK) enters focus after a recent trading session that left the share price at US$119.07, prompting inves...
Key Points Merck's outlook is bright despite challenges to its core franchises. Novartis is performing well despite a recent major patent cliff. Both are att...
Merck (NYSE: MRK) rose after six straight sessions of losses, with shares up 2.17% at $117.97 on Friday afternoon. Over the prior six sessions, the stock had f...
Merck (MRK) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influenc...
Shareholder groups have filed new proposals for Merck’s 2026 Annual Meeting targeting DEI related recruitment practices, gender based compensation and benefits...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.